Anbio Biotechnology Class A Ordinary Shares
NNNNNASDAQ · Healthcare · Medical - Instruments & SuppliesAnbio Biotechnology provides in vitro diagnostics (IVD) products in the European Union, the Asia Pacific, North America, South America, Africa, and internationa…
$3.89+8.36%
报价 2026-11-06
市值
$170.7M
EV
$159.5M
PE (TTM)
19.7x
预期 PE
–
52 周区间距高点 -90.5%
$3.13$41.11
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
同行业市值相近 · Medical - Instruments & Supplies| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| NNNNAnbio Biotechnology Class A Ordinary Shares | $170.7M | +8.4% | – | 86.1% | 19.7x | 24.6x | – | |
| SMTISanara MedTech Inc. | $289.9M | -0.2% | +14.4% | 91.3% | – | 37.4x | 71.2x | |
| INFUInfuSystem Holdings, Inc. | $272.7M | +1.0% | +0.6% | 57.5% | 29.7x | 12.0x | 13.2x | |
| OSUROraSure Technologies, Inc. | $237.3M | +2.1% | +4.4% | 41% | – | – | – | |
| UTMDUtah Medical Products, Inc. | $229.2M | +1.7% | – | 52.9% | 19.1x | 7.4x | 21.6x | |
| PDEXPro-Dex, Inc. | $202.1M | +3.2% | 0.0% | 31.4% | 17.4x | 17.0x | 34.0x | |
| KRMDKORU Medical Systems, Inc. | $141.9M | +2.0% | +18.8% | 60.3% | – | – | – | |
| STXSStereotaxis, Inc. | $109.2M | +3.8% | +20.1% | 55.6% | – | – | – | |
| NYXHNyxoah S.A. | $86.1M | +4.3% | – | 51.3% | – | – | – | |
| 同行中位数 | – | – | +9.4% | 54.2% | 19.1x | 14.5x | 27.8x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。